[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pancreatic Beta-Cell Protection Market Growth (Status and Outlook) 2022-2028

January 2022 | 114 pages | ID: G0D3204DBB39EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Pancreatic Beta-Cell Protection will have significant change from previous year. According to our (LP Information) latest study, the global Pancreatic Beta-Cell Protection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pancreatic Beta-Cell Protection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Pancreatic Beta-Cell Protection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pancreatic Beta-Cell Protection market, reaching US$ million by the year 2028. As for the Europe Pancreatic Beta-Cell Protection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Pancreatic Beta-Cell Protection players cover ViaCyte, PharmaCyte Biotech, Boehringer Ingelheim, and GalaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pancreatic Beta-Cell Protection market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
  • Stem Cell Based
  • Gene Therapies
  • RNA Based Therapies
  • Monoclonal Antibodies (MAbs)
  • Phytotherapy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
  • Hospital
  • Medical Research Laboratory
  • Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
  • ViaCyte
  • PharmaCyte Biotech
  • Boehringer Ingelheim
  • GalaxoSmithKline
  • Beta-Cell NV
  • Novartis
  • Janssen Research & Development
  • Pfizer Inc
  • BioLineRx
  • Genentech
  • Novo Nordisk
  • Sanofi
  • Osiris Therapeutics
  • Beta-O2 Technologies Ltd
  • Transition Therapeutics
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pancreatic Beta-Cell Protection Market Size 2017-2028
  2.1.2 Pancreatic Beta-Cell Protection Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Pancreatic Beta-Cell Protection Segment by Type
  2.2.1 Stem Cell Based
  2.2.2 Gene Therapies
  2.2.3 RNA Based Therapies
  2.2.4 Monoclonal Antibodies (MAbs)
  2.2.5 Phytotherapy
2.3 Pancreatic Beta-Cell Protection Market Size by Type
  2.3.1 Pancreatic Beta-Cell Protection Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2022)
2.4 Pancreatic Beta-Cell Protection Segment by Application
  2.4.1 Hospital
  2.4.2 Medical Research Laboratory
  2.4.3 Others
2.5 Pancreatic Beta-Cell Protection Market Size by Application
  2.5.1 Pancreatic Beta-Cell Protection Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2022)

3 PANCREATIC BETA-CELL PROTECTION MARKET SIZE BY PLAYER

3.1 Pancreatic Beta-Cell Protection Market Size Market Share by Players
  3.1.1 Global Pancreatic Beta-Cell Protection Revenue by Players (2020-2022)
  3.1.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Players (2020-2022)
3.2 Global Pancreatic Beta-Cell Protection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PANCREATIC BETA-CELL PROTECTION BY REGIONS

4.1 Pancreatic Beta-Cell Protection Market Size by Regions (2017-2022)
4.2 Americas Pancreatic Beta-Cell Protection Market Size Growth (2017-2022)
4.3 APAC Pancreatic Beta-Cell Protection Market Size Growth (2017-2022)
4.4 Europe Pancreatic Beta-Cell Protection Market Size Growth (2017-2022)
4.5 Middle East & Africa Pancreatic Beta-Cell Protection Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Pancreatic Beta-Cell Protection Market Size by Country (2017-2022)
5.2 Americas Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
5.3 Americas Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pancreatic Beta-Cell Protection Market Size by Region (2017-2022)
6.2 APAC Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
6.3 APAC Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pancreatic Beta-Cell Protection by Country (2017-2022)
7.2 Europe Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
7.3 Europe Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pancreatic Beta-Cell Protection by Region (2017-2022)
8.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
8.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PANCREATIC BETA-CELL PROTECTION MARKET FORECAST

10.1 Global Pancreatic Beta-Cell Protection Forecast by Regions (2023-2028)
  10.1.1 Global Pancreatic Beta-Cell Protection Forecast by Regions (2023-2028)
  10.1.2 Americas Pancreatic Beta-Cell Protection Forecast
  10.1.3 APAC Pancreatic Beta-Cell Protection Forecast
  10.1.4 Europe Pancreatic Beta-Cell Protection Forecast
  10.1.5 Middle East & Africa Pancreatic Beta-Cell Protection Forecast
10.2 Americas Pancreatic Beta-Cell Protection Forecast by Country (2023-2028)
  10.2.1 United States Pancreatic Beta-Cell Protection Market Forecast
  10.2.2 Canada Pancreatic Beta-Cell Protection Market Forecast
  10.2.3 Mexico Pancreatic Beta-Cell Protection Market Forecast
  10.2.4 Brazil Pancreatic Beta-Cell Protection Market Forecast
10.3 APAC Pancreatic Beta-Cell Protection Forecast by Region (2023-2028)
  10.3.1 China Pancreatic Beta-Cell Protection Market Forecast
  10.3.2 Japan Pancreatic Beta-Cell Protection Market Forecast
  10.3.3 Korea Pancreatic Beta-Cell Protection Market Forecast
  10.3.4 Southeast Asia Pancreatic Beta-Cell Protection Market Forecast
  10.3.5 India Pancreatic Beta-Cell Protection Market Forecast
  10.3.6 Australia Pancreatic Beta-Cell Protection Market Forecast
10.4 Europe Pancreatic Beta-Cell Protection Forecast by Country (2023-2028)
  10.4.1 Germany Pancreatic Beta-Cell Protection Market Forecast
  10.4.2 France Pancreatic Beta-Cell Protection Market Forecast
  10.4.3 UK Pancreatic Beta-Cell Protection Market Forecast
  10.4.4 Italy Pancreatic Beta-Cell Protection Market Forecast
  10.4.5 Russia Pancreatic Beta-Cell Protection Market Forecast
10.5 Middle East & Africa Pancreatic Beta-Cell Protection Forecast by Region (2023-2028)
  10.5.1 Egypt Pancreatic Beta-Cell Protection Market Forecast
  10.5.2 South Africa Pancreatic Beta-Cell Protection Market Forecast
  10.5.3 Israel Pancreatic Beta-Cell Protection Market Forecast
  10.5.4 Turkey Pancreatic Beta-Cell Protection Market Forecast
  10.5.5 GCC Countries Pancreatic Beta-Cell Protection Market Forecast
10.6 Global Pancreatic Beta-Cell Protection Forecast by Type (2023-2028)
10.7 Global Pancreatic Beta-Cell Protection Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 ViaCyte
  11.1.1 ViaCyte Company Information
  11.1.2 ViaCyte Pancreatic Beta-Cell Protection Product Offered
  11.1.3 ViaCyte Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 ViaCyte Main Business Overview
  11.1.5 ViaCyte Latest Developments
11.2 PharmaCyte Biotech
  11.2.1 PharmaCyte Biotech Company Information
  11.2.2 PharmaCyte Biotech Pancreatic Beta-Cell Protection Product Offered
  11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 PharmaCyte Biotech Main Business Overview
  11.2.5 PharmaCyte Biotech Latest Developments
11.3 Boehringer Ingelheim
  11.3.1 Boehringer Ingelheim Company Information
  11.3.2 Boehringer Ingelheim Pancreatic Beta-Cell Protection Product Offered
  11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Boehringer Ingelheim Main Business Overview
  11.3.5 Boehringer Ingelheim Latest Developments
11.4 GalaxoSmithKline
  11.4.1 GalaxoSmithKline Company Information
  11.4.2 GalaxoSmithKline Pancreatic Beta-Cell Protection Product Offered
  11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 GalaxoSmithKline Main Business Overview
  11.4.5 GalaxoSmithKline Latest Developments
11.5 Beta-Cell NV
  11.5.1 Beta-Cell NV Company Information
  11.5.2 Beta-Cell NV Pancreatic Beta-Cell Protection Product Offered
  11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Beta-Cell NV Main Business Overview
  11.5.5 Beta-Cell NV Latest Developments
11.6 Novartis
  11.6.1 Novartis Company Information
  11.6.2 Novartis Pancreatic Beta-Cell Protection Product Offered
  11.6.3 Novartis Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 Novartis Main Business Overview
  11.6.5 Novartis Latest Developments
11.7 Janssen Research & Development
  11.7.1 Janssen Research & Development Company Information
  11.7.2 Janssen Research & Development Pancreatic Beta-Cell Protection Product Offered
  11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 Janssen Research & Development Main Business Overview
  11.7.5 Janssen Research & Development Latest Developments
11.8 Pfizer Inc
  11.8.1 Pfizer Inc Company Information
  11.8.2 Pfizer Inc Pancreatic Beta-Cell Protection Product Offered
  11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 Pfizer Inc Main Business Overview
  11.8.5 Pfizer Inc Latest Developments
11.9 BioLineRx
  11.9.1 BioLineRx Company Information
  11.9.2 BioLineRx Pancreatic Beta-Cell Protection Product Offered
  11.9.3 BioLineRx Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.9.4 BioLineRx Main Business Overview
  11.9.5 BioLineRx Latest Developments
11.10 Genentech
  11.10.1 Genentech Company Information
  11.10.2 Genentech Pancreatic Beta-Cell Protection Product Offered
  11.10.3 Genentech Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.10.4 Genentech Main Business Overview
  11.10.5 Genentech Latest Developments
11.11 Novo Nordisk
  11.11.1 Novo Nordisk Company Information
  11.11.2 Novo Nordisk Pancreatic Beta-Cell Protection Product Offered
  11.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.11.4 Novo Nordisk Main Business Overview
  11.11.5 Novo Nordisk Latest Developments
11.12 Sanofi
  11.12.1 Sanofi Company Information
  11.12.2 Sanofi Pancreatic Beta-Cell Protection Product Offered
  11.12.3 Sanofi Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.12.4 Sanofi Main Business Overview
  11.12.5 Sanofi Latest Developments
11.13 Osiris Therapeutics
  11.13.1 Osiris Therapeutics Company Information
  11.13.2 Osiris Therapeutics Pancreatic Beta-Cell Protection Product Offered
  11.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.13.4 Osiris Therapeutics Main Business Overview
  11.13.5 Osiris Therapeutics Latest Developments
11.14 Beta-O2 Technologies Ltd
  11.14.1 Beta-O2 Technologies Ltd Company Information
  11.14.2 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product Offered
  11.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.14.4 Beta-O2 Technologies Ltd Main Business Overview
  11.14.5 Beta-O2 Technologies Ltd Latest Developments
11.15 Transition Therapeutics
  11.15.1 Transition Therapeutics Company Information
  11.15.2 Transition Therapeutics Pancreatic Beta-Cell Protection Product Offered
  11.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Revenue, Gross Margin and Market Share (2020-2022)
  11.15.4 Transition Therapeutics Main Business Overview
  11.15.5 Transition Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Pancreatic Beta-Cell Protection Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Stem Cell Based
Table 3. Major Players of Gene Therapies
Table 4. Major Players of RNA Based Therapies
Table 5. Major Players of Monoclonal Antibodies (MAbs)
Table 6. Major Players of Phytotherapy
Table 7. Pancreatic Beta-Cell Protection Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2022)
Table 10. Pancreatic Beta-Cell Protection Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2022)
Table 13. Global Pancreatic Beta-Cell Protection Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Pancreatic Beta-Cell Protection Revenue Market Share by Player (2020-2022)
Table 15. Pancreatic Beta-Cell Protection Key Players Head office and Products Offered
Table 16. Pancreatic Beta-Cell Protection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Pancreatic Beta-Cell Protection Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Pancreatic Beta-Cell Protection Market Size Market Share by Regions (2017-2022)
Table 21. Americas Pancreatic Beta-Cell Protection Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Pancreatic Beta-Cell Protection Market Size Market Share by Country (2017-2022)
Table 23. Americas Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2022)
Table 25. Americas Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2022)
Table 27. APAC Pancreatic Beta-Cell Protection Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Pancreatic Beta-Cell Protection Market Size Market Share by Region (2017-2022)
Table 29. APAC Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2022)
Table 31. APAC Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2022)
Table 33. Europe Pancreatic Beta-Cell Protection Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Pancreatic Beta-Cell Protection Market Size Market Share by Country (2017-2022)
Table 35. Europe Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2022)
Table 37. Europe Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Pancreatic Beta-Cell Protection Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Pancreatic Beta-Cell Protection
Table 46. Key Market Challenges & Risks of Pancreatic Beta-Cell Protection
Table 47. Key Industry Trends of Pancreatic Beta-Cell Protection
Table 48. Global Pancreatic Beta-Cell Protection Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Pancreatic Beta-Cell Protection Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Pancreatic Beta-Cell Protection Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Pancreatic Beta-Cell Protection Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Pancreatic Beta-Cell Protection Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Pancreatic Beta-Cell Protection Market Size Market Share Forecast by Application (2023-2028)
Table 54. ViaCyte Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 55. ViaCyte Pancreatic Beta-Cell Protection Product Offered
Table 56. ViaCyte Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. ViaCyte Main Business
Table 58. ViaCyte Latest Developments
Table 59. PharmaCyte Biotech Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 60. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product Offered
Table 61. PharmaCyte Biotech Main Business
Table 62. PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. PharmaCyte Biotech Latest Developments
Table 64. Boehringer Ingelheim Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 65. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product Offered
Table 66. Boehringer Ingelheim Main Business
Table 67. Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Boehringer Ingelheim Latest Developments
Table 69. GalaxoSmithKline Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 70. GalaxoSmithKline Pancreatic Beta-Cell Protection Product Offered
Table 71. GalaxoSmithKline Main Business
Table 72. GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. GalaxoSmithKline Latest Developments
Table 74. Beta-Cell NV Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 75. Beta-Cell NV Pancreatic Beta-Cell Protection Product Offered
Table 76. Beta-Cell NV Main Business
Table 77. Beta-Cell NV Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Beta-Cell NV Latest Developments
Table 79. Novartis Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 80. Novartis Pancreatic Beta-Cell Protection Product Offered
Table 81. Novartis Main Business
Table 82. Novartis Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Novartis Latest Developments
Table 84. Janssen Research & Development Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 85. Janssen Research & Development Pancreatic Beta-Cell Protection Product Offered
Table 86. Janssen Research & Development Main Business
Table 87. Janssen Research & Development Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Janssen Research & Development Latest Developments
Table 89. Pfizer Inc Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 90. Pfizer Inc Pancreatic Beta-Cell Protection Product Offered
Table 91. Pfizer Inc Main Business
Table 92. Pfizer Inc Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Pfizer Inc Latest Developments
Table 94. BioLineRx Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 95. BioLineRx Pancreatic Beta-Cell Protection Product Offered
Table 96. BioLineRx Main Business
Table 97. BioLineRx Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. BioLineRx Latest Developments
Table 99. Genentech Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 100. Genentech Pancreatic Beta-Cell Protection Product Offered
Table 101. Genentech Main Business
Table 102. Genentech Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Genentech Latest Developments
Table 104. Novo Nordisk Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 105. Novo Nordisk Pancreatic Beta-Cell Protection Product Offered
Table 106. Novo Nordisk Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. Novo Nordisk Main Business
Table 108. Novo Nordisk Latest Developments
Table 109. Sanofi Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 110. Sanofi Pancreatic Beta-Cell Protection Product Offered
Table 111. Sanofi Main Business
Table 112. Sanofi Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Sanofi Latest Developments
Table 114. Osiris Therapeutics Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 115. Osiris Therapeutics Pancreatic Beta-Cell Protection Product Offered
Table 116. Osiris Therapeutics Main Business
Table 117. Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Osiris Therapeutics Latest Developments
Table 119. Beta-O2 Technologies Ltd Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 120. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product Offered
Table 121. Beta-O2 Technologies Ltd Main Business
Table 122. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Beta-O2 Technologies Ltd Latest Developments
Table 124. Transition Therapeutics Details, Company Type, Pancreatic Beta-Cell Protection Area Served and Its Competitors
Table 125. Transition Therapeutics Pancreatic Beta-Cell Protection Product Offered
Table 126. Transition Therapeutics Main Business
Table 127. Transition Therapeutics Pancreatic Beta-Cell Protection Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Transition Therapeutics Latest Developments

LIST OF FIGURES

Figure 1. Pancreatic Beta-Cell Protection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pancreatic Beta-Cell Protection Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Pancreatic Beta-Cell Protection Market Size Market Share by Type in 2021
Figure 7. Pancreatic Beta-Cell Protection in Hospital
Figure 8. Global Pancreatic Beta-Cell Protection Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Pancreatic Beta-Cell Protection in Medical Research Laboratory
Figure 10. Global Pancreatic Beta-Cell Protection Market: Medical Research Laboratory (2017-2022) & ($ Millions)
Figure 11. Pancreatic Beta-Cell Protection in Others
Figure 12. Global Pancreatic Beta-Cell Protection Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Pancreatic Beta-Cell Protection Market Size Market Share by Application in 2021
Figure 14. Global Pancreatic Beta-Cell Protection Revenue Market Share by Player in 2021
Figure 15. Global Pancreatic Beta-Cell Protection Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Pancreatic Beta-Cell Protection Market Size 2017-2022 ($ Millions)
Figure 17. APAC Pancreatic Beta-Cell Protection Market Size 2017-2022 ($ Millions)
Figure 18. Europe Pancreatic Beta-Cell Protection Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Pancreatic Beta-Cell Protection Market Size 2017-2022 ($ Millions)
Figure 20. Americas Pancreatic Beta-Cell Protection Value Market Share by Country in 2021
Figure 21. Americas Pancreatic Beta-Cell Protection Consumption Market Share by Type in 2021
Figure 22. Americas Pancreatic Beta-Cell Protection Market Size Market Share by Application in 2021
Figure 23. United States Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Pancreatic Beta-Cell Protection Market Size Market Share by Region in 2021
Figure 28. APAC Pancreatic Beta-Cell Protection Market Size Market Share by Application in 2021
Figure 29. China Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Pancreatic Beta-Cell Protection Market Size Market Share by Country in 2021
Figure 36. Europe Pancreatic Beta-Cell Protection Market Size Market Share by Type in 2021
Figure 37. Europe Pancreatic Beta-Cell Protection Market Size Market Share by Application in 2021
Figure 38. Germany Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Pancreatic Beta-Cell Protection Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Pancreatic Beta-Cell Protection Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Pancreatic Beta-Cell Protection Market Size Market Share by Application in 2021
Figure 46. Egypt Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Pancreatic Beta-Cell Protection Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 52. APAC Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 53. Europe Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 55. United States Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 56. Canada Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 59. China Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 60. Japan Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 61. Korea Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 63. India Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 64. Australia Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 65. Germany Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 66. France Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 67. UK Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 68. Italy Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 69. Russia Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 70. Spain Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 73. Israel Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Pancreatic Beta-Cell Protection Market Size 2023-2028 ($ Millions)


More Publications